The syrup, containing a concentrated extract of rose hip fruit, is commonly used in traditional systems of supportive care. As an ingredient, rose hip may be part of symptomatic management in situations where patients experience discomfort.

This preparation is relevant for easing symptoms linked to organ-specific functional stress within the biliary system, particularly its traditional role as a cholagogue (a substance that helps increase bile flow). The preparation may assist with supportive relief in contexts involving conditions presenting with systemic or localized discomfort, specifically those associated with episodic or fluctuating manifestations of the biliary system.

Quick Fact: Relief for Symptoms Related to Physical Discomfort

This is applied when appropriate in clinical settings that involve acute or unstable symptom patterns, or when symptoms become more noticeable. The extract helps ease the overall symptom burden during symptomatic phases and may help patients cope more steadily with symptom fluctuations. It assists with maintaining functional stability when symptoms are more noticeable, supporting general well-being in contexts involving inflammatory or irritative states.

Regulatory References

1. Health Canada Natural Health Products Ingredients Database

Eligibility Rules for Холос

The eligibility for using Холос (Rose Hip Thick Extract syrup) is determined by official regulatory documents, which define absolute prohibitions (contraindications) and specific population restrictions. As a choleretic agent that stimulates bile flow, its use is prohibited in conditions where this action could cause harm.

---

Contraindicated Populations (Must Not Use)

The medicine is absolutely contraindicated for patients with:

• Hypersensitivity to the active ingredient or excipients.
• Mechanical obstruction of the biliary tract, including obstructive jaundice.
• Gallstone disease (cholelithiasis) or calculous cholecystitis.
• Acute Hepatitis or Cirrhosis.
• Peptic Ulcer of the stomach or duodenum.

---

Restricted and Age-Based Use

Population Group	Regulatory Status
Children under 3 years	Not recommended (use not established).
Pregnant/Lactating Women	Not recommended (conditional restriction).
Diabetes Mellitus	Caution required (due to syrup's sucrose content).

The medicine is permitted for use in adults and children aged 3 years and older who do not have any of the listed contraindications.

Interactions with other medicines and products

Official regulatory information for Холос (Rose Hip Thick Extract) documents several clinically significant interactions, primarily classified as exposure-modifying or involving pharmacodynamic alterations of co-administered substances. These patterns are largely attributed to the extract's high Ascorbic Acid (Vitamin C) content and its functional effect on gastrointestinal absorption.

Documented Exposure-Altering Interactions

Co-administration with Eltrombopag is documented as a highly restricted combination due to inhibition of gastrointestinal absorption, resulting in significantly reduced Eltrombopag plasma levels. The label mandates strict timing separation for this combination, requiring administration at least four hours apart.

Pharmacokinetic and Pharmacodynamic Effects

The extract is documented to reduce the plasma concentrations of several medicines, including Tetracycline and Quinolone antibiotics, as well as Mycophenolate, through an inhibition of GI uptake. Conversely, the extract may increase the exposure of Estrogens and decrease the renal clearance of Lithium.

Interactions with Supplements and Timing Constraints

The Ascorbic Acid component may decrease the anticoagulant effect of Warfarin. Furthermore, it increases the absorption of iron-containing supplements and food. Aluminum-containing Antacids require mandatory time spacing, specifically a separation of two hours before or four hours after antacid administration, to manage absorption. Specific caution is noted for patients with cardiac failure undergoing Deferoxamine treatment.

▷ Choleresis Driven by Osmotic Flow Promotion

The core mechanism of Холос is its action as an osmotic choleretic, primarily focused on the hepatocytes (liver cells). The extract's bioactive constituents, particularly the organic acids, are secreted into the bile canaliculi, which generates a strong osmotic gradient. This gradient actively draws water and electrolytes from the surrounding tissue, dramatically increasing the volume and flow rate of the bile fluid. This increase in aqueous bile output enhances fluid movement through the biliary system.

▷ Multi-Component Synergy and Cellular Support

The mechanism involves intra-extract synergy, where the collective action of multiple compounds is necessary to realize the complete pharmacodynamic action. While the osmotic action drives the volume, the flavonoids and other phenolics modulate the internal cellular environment of the liver. By acting as antioxidants, these components contribute to the functional integrity of the hepatocytes against oxidative stress, which is relevant for the cell's capacity to maintain secretory activity required by the choleretic mechanism.

Official Administration Guidelines for Холос

This section outlines the procedural steps and official dosing instructions for Холос and does not contain therapeutic advice or safety information.

---

Administration Protocol

Route of Administration: Oral use only. It is administered as supplied without further preparation such as dilution or shaking.

Timing and Frequency:

• The product must be consumed 1 hour before a meal.
• The duration of a course of administration is generally 20 to 40 days.

---

Official Dosing Schedule

The dosage is determined by age and the administration is to be followed daily:

Age Group	Single Dose (Volume)	Maximum Daily Frequency
Children 3 to 15 years	2.5 to 5 ml (1/2 to 1 teaspoon)	Once daily
Adults & Children > 15 years	5 ml (1 teaspoon)	One to three times daily

---

Procedural Rules

• Missed Dose Instructions: If a dose is missed, the next scheduled dose should be taken at the usual time. Do not attempt to take a double dose to compensate for the skipped one.
• Course Repeats: Repeating the 20–40 day administration course is permitted, but must be determined and prescribed by a healthcare professional.

Research Evidence and Overview of Studies for Холос (Rosae Pingue Fructuum Extract)

---

Evidence for Use in Supportive Care for Bile Dynamics

The primary regulatory classification of Холос is for supportive care of the hepatobiliary system; its physiological action was studied as a choleretic effect (promoting bile dynamics). Research exploring this extract was conducted in contexts involving conditions characterized by fluctuating or episodic manifestations where symptoms may vary in intensity. This evidence is applied in studies examining patient-reported experiences related to physical discomfort linked to functional imbalance in the biliary system.

The overall evidence base for this specific concentrated syrup formulation relies heavily on documentation of traditional use, and consequently, it is not primarily driven by extensive modern clinical trials. Research documents how the preparation was historically used in settings involving physiological strain or stress on the biliary system. Research summarizes short-term changes and reports on how patients described their experience during periods of heightened symptom activity.

---

The Landscape of Studies: Preclinical Data and Traditional Registrations

The foundational evidence for the choleretic action was primarily explored through preclinical pharmacology studies, meaning laboratory research (in vitro and animal models), not human clinical trials. These studies examined basic patterns of activity that were observed in the laboratory settings. The primary outcomes measured in these preclinical studies included the volume of bile secretion and the rate of bile flow in animal models.

In humans, the evidence for supportive care is derived from bibliographic data on traditional use. Dedicated, placebo-controlled randomized clinical trials (RCTs) that directly evaluated the specific concentrated rose hip thick syrup in human subjects for its choleretic purpose are not widely documented in major governmental or peer-reviewed scientific databases. The studies monitored outcomes related to functional imbalance; however, comparative evidence against a placebo is not publicly documented.

---

What Remains Uncertain About the Research for Холос

A primary limitation of the research record is the scarcity of high-quality human clinical trials specific to the concentrated rose hip syrup used as a choleretic. Consequently, the level of certainty remains low regarding outcomes for this specific preparation in randomized clinical settings. The available research provides context but not individual predictions, and the evidence quality varies across studies, reflecting uncertainty in findings. Comparative evidence is not publicly documented; the available evidence describes group patterns and does not establish individual predictive outcomes.

Key Studies & References Health Canada Natural Health Products Ingredients Database - Rose hip

Common questions about Холос (FAQ)

---

Q: Can Холос be used for long periods?

A: The official administration course for Холос is typically limited to a duration of 20 to 40 days. Repeating this course is permitted according to regulatory guidelines, however, the decision to repeat administration is typically discussed with a healthcare professional, as documented in official procedural rules.

---

Q: Does Холос have any effect on blood sugar levels?

A: Official guidance advises caution for individuals with Diabetes Mellitus when considering the use of Холос. This is due to the presence of sucrose (sugar) content in the syrup formulation, a fact which is documented in the product's official safety information.

---

Q: What are the official restrictions for people with a history of heart conditions?

A: General restrictions for a history of heart conditions are not listed as an absolute contraindication for Холос. However, official documents note a specific caution for patients with cardiac failure who are undergoing treatment with Deferoxamine.

---

Q: Does official guidance say about using Холос with alcohol?

A: The official regulatory information regarding drug interactions does not specifically document a known interaction or warning about the concurrent use of Холос with alcohol.

---

Q: What does official labeling include any mention of its use for weight management?

A: The general regulatory purpose of Холос is listed as supportive care for the hepatobiliary system (the liver and bile ducts). Weight management is not listed as an approved or official use in the product labeling.

---

Q: Is it okay for teenagers to use Холос?

A: The official dosing schedule provides specific administration volumes for children aged 3 to 15 years and for individuals aged 15 years and older (who follow the adult dose). Regulatory documents note restrictions or cautions for use in children under 12 years.

---

Q: Does Холос affect the efficacy of birth control pills?

A: Regulatory documents indicate that the extract may increase the exposure of Estrogens in the body. Users should be aware of this documented interaction when discussing their medication profile with a healthcare provider.

---

Q: Is Холос considered a natural or herbal remedy?

A: Yes, official documents classify Холос as a phytopreparation of natural origin. A phytopreparation is a medicine whose active ingredient is derived from plants, in this case, Rose Hip Thick Extract.

---

Q: What are the general differences between Холос and other similar products I see advertised?

A: Official regulatory information classifies the product as a single-ingredient phytopreparation. Its specific physiological action is defined as an osmotic choleretic agent, meaning it works by promoting the volume and flow of bile.

---

Q: What does 'works by supporting liver function' actually mean?

A: The regulatory-defined action is the choleretic effect, which is described as its role in supporting the hepatobiliary system. This effect involves stimulating liver cells (hepatocytes) to increase the production and flow rate of bile secretion.

---

Q: Are there any known issues with taking Холос alongside vitamins or supplements?

A: Official documents describe an interaction where the Ascorbic Acid (Vitamin C) component of the extract may increase the absorption of iron-containing supplements. Always check the official interaction list against any supplements you use.

---

Q: What kind of research has been done on the main compound in Холос?

A: Research includes preclinical pharmacology studies (laboratory or animal models) that examined basic patterns such as bile secretion volume and flow rate. The evidence base also relies on bibliographic data documenting the compound's long history of traditional use.

---

Q: What happens if I accidentally miss a time to use Холос?

A: The official procedural rule for a missed dose is to take the next scheduled dose at the usual time. The procedural rule advises against taking a double dose to compensate for the skipped one.

---

Q: How should I confirm if a specific condition is treated by Холос?

A: To confirm its approved use, you should refer to the official regulatory documents. These classify the general purpose of Холос as supportive care for the hepatobiliary system.

---

Q: Why is Холос sometimes recommended for gallbladder issues?

A: The medicine is officially classified as a choleretic agent because it stimulates bile flow. Its general purpose is supportive care for the entire hepatobiliary system, which includes the gallbladder and bile ducts.

---

Q: Can men and women use Холос the same way?

A: Yes. Official administration guidelines list dosing strictly by age group, such as children 3 to 15 years, and adults and children over 15 years. No separate dosing or procedural rules are documented for men versus women.

Official Storage and Disposal Requirements

Regulatory documents define specific non-advisory rules for the storage and disposal of Холос to ensure product stability and safety.

Requirement	Stated Condition
Temperature Range	Store at controlled room temperature, 15 C to 25 C (Do Not Freeze).
Environmental Control	Mandatory protection from direct sunlight, intense light, and excessive moisture.
Stability After Opening	Use product within 30 days of opening the container.
Child Safety	KEEP OUT OF THE SIGHT AND REACH OF CHILDREN.

The medicine must remain in its original, tightly closed, light-resistant container until use. Do not discard unused or expired Холос in household trash, down a sink, or into the toilet. Disposal must follow official pharmaceutical take-back programs or authorized collection points, complying with local environmental regulations for non-hazardous pharmaceutical waste.